Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- Nasdaq drags on Wall St as AI slowdown fears hammer Nvidia, chipmakers
- Global AI stocks fall as industry chiefs call for slowing development
- Oil prices continue surge, rising 3% as attacks halt Saudi pipeline
- BofA sees just 2% upside for the S&P 500 over the next 12 months
- Wall Street's new pair trade: Long software, short chips
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Inari Medical Inc. (NARI) PT Lowered to $108 at Morgan Stanley
February 24, 2022 8:55 AM ESTMorgan Stanley analyst Cecilia Furlong lowered the price target on Inari Medical Inc. (NASDAQ: NARI) to $108.00 (from $119.00) while maintaining a Overweight rating.
... MoreInari Medical, Inc. (NARI) Misses Q4 EPS by 1c
February 23, 2022 4:54 PM ESTInari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $78.16 million.
For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.
... More